InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Jones Erika, Autre. Director active across 1 companies, notably Black Diamond Therapeutics, Inc.. Cumulatively, 2 filings have been logged. The latest transaction was disclosed on 15 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
05,075 shares0
Common Stock
SEC:0001415889-22-001515:0·
05,075 shares0
Common Stock
SEC:0001415889-22-001515·
2 of 2 declarations
About Jones Erika
Erika Jones is involved in various functions at Black Diamond Therapeutics, Inc. While the details of her role are not specified, she contributes to the company's mission in the biopharmaceutical sector. Her expertise is valuable for developing innovative solutions.
